These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35219595)

  • 21. Cyclopentenone-containing oxidized phospholipids and their isoprostanes as pro-resolving mediators of inflammation.
    Friedli O; Freigang S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):382-392. PubMed ID: 27422370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
    Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
    J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin A1 and the regulation of innate and adaptive immunity.
    Gavins FN; Hickey MJ
    Front Immunol; 2012; 3():354. PubMed ID: 23230437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?
    Dalli J
    Mol Aspects Med; 2017 Dec; 58():12-20. PubMed ID: 28365269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.
    Vital SA; Senchenkova EY; Ansari J; Gavins FNE
    Cells; 2020 Nov; 9(11):. PubMed ID: 33202930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of annexin A1 in human placental response to maternal Zika virus infection.
    Molás RB; Ribeiro MR; Ramalho Dos Santos MJC; Borbely AU; Oliani DV; Oliani AH; Nadkarni S; Nogueira ML; Moreli JB; Oliani SM
    Antiviral Res; 2020 Jul; 179():104809. PubMed ID: 32360947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.
    Qin C; Yang YH; May L; Gao X; Stewart AG; Tu Y; Woodman OL; Ritchie RH
    Pharmacol Ther; 2015 Apr; 148():47-65. PubMed ID: 25460034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence.
    Thornton JM; Yin K
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation.
    Basil MC; Levy BD
    Nat Rev Immunol; 2016 Jan; 16(1):51-67. PubMed ID: 26688348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular regulators of resolution of inflammation: potential therapeutic targets in the reproductive system.
    Hutchinson JL; Rajagopal SP; Sales KJ; Jabbour HN
    Reproduction; 2011 Jul; 142(1):15-28. PubMed ID: 21490125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quenching the fires: Pro-resolving mediators, air pollution, and smoking.
    Thatcher TH; Woeller CF; McCarthy CE; Sime PJ
    Pharmacol Ther; 2019 May; 197():212-224. PubMed ID: 30759375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders.
    Livshits G; Kalinkovich A
    Pharmacol Res; 2021 Feb; 164():105340. PubMed ID: 33276103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1.
    Lima KM; Vago JP; Caux TR; Negreiros-Lima GL; Sugimoto MA; Tavares LP; Arribada RG; Carmo AAF; Galvão I; Costa BRC; Soriani FM; Pinho V; Solito E; Perretti M; Teixeira MM; Sousa LP
    J Biol Chem; 2017 Aug; 292(33):13758-13773. PubMed ID: 28655761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annexin-A1: Therapeutic Potential in Microvascular Disease.
    Purvis GSD; Solito E; Thiemermann C
    Front Immunol; 2019; 10():938. PubMed ID: 31114582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heart.
    Gavins FN; Leoni G; Getting SJ
    ScientificWorldJournal; 2006 Aug; 6():1008-23. PubMed ID: 16937007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin-A1 restricts Th17 cells and attenuates the severity of autoimmune disease.
    Yazid S; Gardner PJ; Carvalho L; Chu CJ; Flower RJ; Solito E; Lee RW; Ali RR; Dick AD
    J Autoimmun; 2015 Apr; 58():1-11. PubMed ID: 25619792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The resolution of inflammation: Principles and challenges.
    Headland SE; Norling LV
    Semin Immunol; 2015 May; 27(3):149-60. PubMed ID: 25911383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation.
    Radbakhsh S; Katsiki N; Santos RD; Mikhailidis DP; Mantzoros CS; Sahebkar A
    Metabolism; 2022 Jul; 132():155211. PubMed ID: 35533891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
    Norling LV; Serhan CN
    J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.